发明名称 |
Nanoparticle containing prostaglandin I<sub>2 </sub>derivative |
摘要 |
There is provided a beraprost sodium-containing nanoparticle that contains beraprost sodium among other prostaglandin I2 (prostacyclin) derivatives, which are therapeutic agents for pulmonary hypertension. The beraprost sodium-containing nanoparticle is obtained by making beraprost sodium hydrophobic using a metal ion and allowing the hydrophobic beraprost sodium to react with poly-L-lactic acid or a poly(L-lactic acid/glycolic acid) copolymer, and a poly-DL- or L-lactic acid-polyethylene glycol block copolymer or a poly(DL- or L-lactic acid/glycolic acid)-polyethylene glycol block copolymer. The beraprost sodium-containing nanoparticle excels in sustained release of an active ingredient, reduces a side effect, and furthermore, has an excellent drug retention in the blood. Therefore, the beraprost sodium-containing nanoparticle is quite outstanding particularly regarding the sustainability of the medicinal effect. |
申请公布号 |
US9161986(B2) |
申请公布日期 |
2015.10.20 |
申请号 |
US201213984556 |
申请日期 |
2012.02.13 |
申请人 |
LTT BIO-PHARMA CO., LTD. |
发明人 |
Mizushima Toru;Ishihara Tsutomu;Liu Hongxing |
分类号 |
A61K31/5585;A61K9/51;A61K47/34;A61K47/48;A61K47/30;A61K31/343 |
主分类号 |
A61K31/5585 |
代理机构 |
Drinker Biddle & Reath LLP |
代理人 |
Drinker Biddle & Reath LLP |
主权项 |
1. A beraprost sodium-containing nanoparticle for treatment of pulmonary hypertension obtained by:
(a) converting beraprost sodium represented by the following formula (I): to a hydrophobicized beraprost sodium using a metal ion; and (b) allowing the hydrophobicized beraprost sodium to react with poly-L-lactic acid or a poly(L-lactic acid/glycolic acid) copolymer, and a poly-DL- or L-lactic acid-polyethylene glycol block copolymer or a poly(DL- or L-lactic acid/glycolic acid)-polyethylene glycol block copolymer to obtain a beraprost sodium-containing nanoparticle. |
地址 |
Tokyo JP |